Simplify Logo

Full-Time

Senior Director

Device Development & Manufacturing

Posted on 4/18/2024

BlueRock Therapeutics

BlueRock Therapeutics

201-500 employees

Clinical stage cell therapy company

Hardware
Biotechnology

Senior

Toronto, ON, Canada

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Quality Assurance (QA)
Requirements
  • Bachelor’s or Master’s degree or equivalent, or PhD with 12+ years of experience
  • Experience with biologic product delivery
  • Thorough understanding of Design Controls and cGMP requirements compliant with ISO 13485 and the QSR (21 CFR Part 820)
  • Significant experience in development and validation of medical device manufacturing processes and technologies
  • Demonstrated cross functional leader with successful track record of delivering projects on time and within budget
  • Working knowledge of quality statistics
  • Experience in managing external development and manufacturing or other such business partnerships
  • Solid understanding of aseptic techniques and technologies and operating room procedures
  • Competency in computer skills and familiarity with Microsoft Office
  • Experience leader in delivering products through IND
Responsibilities
  • Provides leadership for device development and manufacturing activities
  • Liaises with QA, RA, and program team
  • Works in collaboration with cross-functional peers and team members
  • Identifies and assesses new product and manufacturing technologies
  • Acts as product development subject matter expert
  • Takes a leadership role in medical and combination device product development efforts
  • Collaborates with engineers and cross-functional product development teams
  • Ensures compliance with relevant regulatory standards and guidance
  • Writes, amends, and reviews plan documents and other documentation
  • Mentors and trains engineers, technicians, and assemblers
BlueRock Therapeutics

BlueRock Therapeutics

View

BlueRock Therapeutics is a clinical stage cell therapy company focused on harnessing the power of cell therapy to replace damaged or lost cells in order to create medicines for neurology, cardiology, and immunology indications. Their cell+gene platform utilizes cell differentiation technology to produce authentic cell therapies, with the potential to restore or regenerate lost function.

Company Stage

M&A

Total Funding

$807M

Headquarters

Toronto, Canada

Founded

2016

Growth & Insights
Headcount

6 month growth

7%

1 year growth

-1%

2 year growth

40%
INACTIVE